In line with the BBB permeability data, stroke-induced loss of tight junction proteins including ZO-1 and occludin was significantly attenuated by CAY10404 treatment in the ischemic brain (Figures 5G–I), which were associated with significant reduction of MMP-9 activity (Figure 5F). This evidence concerns the gene TJP1 and stroke disorder.